Episode Details
Back to Episodes
Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results
Description
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/smart-contact-lenses-for-iop-monitoring-august-2026-clinical-utility-results
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results Evidence cutoff: August 23, 2026 Introduction Continuous intraocular pressure monitoring could reveal pressure changes that are easily missed during a routine eye examination—especially pressure increases during sleep, while lying down, or outside normal office hours. Standard clinic testing usually provides only a few measurements each year, most often while the patient is awake and seated. The technology has advanced substantially. However, the clinical evidence available by August 23, 2026 still supports smart contact lenses mainly as research and specialized monitoring tools, not as replacements for routine glaucoma examinations or as stand-alone devices for making treatment decisions. The most important distinction is between: Analytical validity: whether the device detects pressure-related changes. Clinical validity: whether those patterns are associated with glaucoma progression or treatment response. Clinical utility: whether using the device improves treatment decisions and patient outcomes. By August 2026, analytical validity is promising for several devices. Clinical validity is emerging. Clinical utility—particularly fewer visual-field losses, fewer urgent visits, or better long-term glaucoma control—has not yet been proven. Executive Summary The newest peer-reviewed clinical report, published June 23, 2026, described a soft contact lens with a sleep-mask reader that detected posture-related and closed-eye pressure changes. Human testing was very small and did not establish overnight adherence, data completeness, or treatment benefit. PubMed () A newer human accuracy study involving 80 eyes found that a contact lens sensor had generally favorable agreement with Goldmann applanation tonometry and supine Perkins tonometry. More than 80% of comparisons were within 5 millimeters of mercury, but the study was short-term and did not evaluate treatment outcomes. Full text () The United States Food and Drug Administration-authorized SENSIMED Triggerfish detects relative ocular dimensional changes, not a directly interchangeable Goldmann pressure value. Its intended clinical role is to identify potentially important pressure-related time periods for follow-up testing. United States Food and Drug Administration review () In an early observational Triggerfish study, 13 of 15 patients, or 87%, completed 24-hour monitoring, and treatment was changed in 11 of 15 patients, or 73%, after the tracing was reviewed. These were clinician decisions after reviewing a completed recording—not responses to validated real-time alerts. PubMed Study report () No publicly available August 2026 study demonstrated that an automated contact lens alert improved visual-field preservation, reduced glaucoma progression, or reliably changed management through a predefined alert protocol. Home rebound tonometry remains more clinically established than experimental smart lenses because it provides a conventional pressure number. It is intermittent, requires training, and still cannot replace clinic-based assessment. European Glaucoma Society guideline () What the August 2026 Evidence Actually Shows For the full table, please open this article on visualfieldtest.com. The Japanese study registry is important because it represents a relatively larger cont